Skip to main content
Atrás
Watch Compare

Aura Biosciences, Inc.

Calidad de datos: 83%
AURA
Nasdaq Manufacturing Chemicals
$6.80
▲ $0.02 (0.30%)
Cap. Mercado: 434.62 M
Precio
$6.78
Cap. Mercado
434.62 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -85.19 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-64.11%
Below sector avg (-53.41%)
ROIC-49.40%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio9.04
Interest CoverageN/A

Valoración

PE (TTM)
-4.09
Below sector avg (-1.48)
P/B Ratio2.77
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -4.1 -1.5
P/B 2.8 1.6
ROE % -64.1 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

CNCR CNCR
1.32% weight
HAUZ logo HAUZ Xtrackers International Real Estate ETF
0.10% weight
AVDS logo AVDS Avantis International Small Cap Equity ETF
0.04% weight
WMMRX WMMRX
0.02% weight
WMRIX WMRIX
0.02% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.02% weight
AVSD logo AVSD Avantis Responsible International Equity ETF
0.01% weight
IRSSX IRSSX
0.01% weight
IRSIX IRSIX
0.01% weight
IIRSX IIRSX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -106.19 M
ROE -64.11% ROA -53.85%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -85.19 M
ROIC -49.40% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 9.04
Interest Coverage N/A Asset Turnover N/A
Working Capital 151.30 M Tangible Book Value 156.67 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.09 Forward P/E N/A
P/B Ratio 2.77 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19.60%
Market Cap 434.62 M Enterprise Value 387.07 M
Per Share
EPS (Diluted TTM) -1.76 Revenue / Share N/A
FCF / Share -1.33 OCF / Share -1.32
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80.22%
SBC-Adj. FCF -98.97 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -106.19 M -86.92 M -76.41 M -58.76 M -35.25 M
EPS (Diluted) -1.76 -1.75 -1.93 -1.96 —
Gross Profit — — — — —
Operating Income -112.79 M -96.12 M -84.99 M -60.30 M -35.25 M
EBITDA — — — — —
R&D Expenses 90.30 M 73.30 M 65.23 M 42.24 M 25.16 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 108,000.0 112,000.0 137,000.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 169.43 M 182.50 M 255.08 M 223.94 M 160.03 M
Total Liabilities 32.52 M 30.53 M 29.23 M 28.35 M 7.72 M
Shareholders' Equity 136.91 M 151.97 M 225.85 M 195.58 M 152.32 M
Total Debt — — — — —
Cash & Equivalents 59.52 M 31.69 M 41.06 M 121.58 M 149.06 M
Current Assets 149.74 M 160.62 M 231.79 M 196.70 M 153.70 M
Current Liabilities 18.38 M 14.91 M 12.36 M 10.46 M 7.27 M